Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Sell
5,414
-307
-5% -$28.6K 0.05% 121
2026
Q1
$556K Sell
5,721
-75
-1% -$6.86K 0.07% 97
2025
Q4
$512K Sell
5,796
-75
-1% -$6.83K 0.06% 128
2025
Q3
$528K Buy
5,871
+189
+3% +$15.3K 0.07% 127
2025
Q2
$431K Buy
5,682
+209
+4% +$15.5K 0.06% 137
2025
Q1
$391K Sell
5,473
-722
-12% -$56.3K 0.07% 140
2024
Q4
$543K Buy
6,195
+125
+2% +$10.9K 0.1% 94
2024
Q3
$508K Sell
6,070
-300
-5% -$24K 0.1% 105
2024
Q2
$484K Sell
6,370
-36
-0.6% -$2.66K 0.1% 110
2024
Q1
$460K Buy
+6,406
New +$459K 0.1% 114

Other funds holding SRE

MJP Associates's SRE Position: Q2 2026 in Review

MJP Associates reduced its Sempra (SRE) stake by 5.4% in Q2 2026, selling an estimated $28.6K and leaving 5,414 shares worth $502K. The position accounts for 0.05% of the portfolio, ranked #121.

MJP Associates first reported a position in SRE in Q1 2024 and has held it in 10 quarters since. The position peaked at $556K in Q1 2026. 1,289 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • MJP Associates held 5,414 shares of Sempra worth $502K as of Q2 2026.
  • MJP Associates sold 307 Sempra shares in Q2 2026, an estimated $28.6K.
  • Sempra made up 0.05% of MJP Associates's portfolio in Q2 2026, its #121 holding.
  • MJP Associates first reported a position in Sempra in Q1 2024 and has held it in 10 quarters since.
  • MJP Associates's Sempra position peaked at $556K in Q1 2026.
  • 1,289 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.